Hepatitis B seroprotection in children aged 10-15 years after completion of basic hepatitis B immunizations

  • Novie Homenta Rampengan Departments of Child Health, Sam Ratulangi University Medical School, Manado
  • Sri Rezeki Hadinegoro Departments of Child Health, University of Indonesia Medical School, Jakarta
  • Mulya Rahma Karyanti Departments of Child Health, University of Indonesia Medical School, Jakarta
DOI: https://doi.org/10.14238/pi57.2.2017.76-83
Keywords: Seroprotection, anti-HBs titer, factors influenced anti-HBs titer

Abstract

Background The prevalence of hepatitis B viral (HBV) infection in Indonesia is high. The most effective way to control HBV infection is by hepatitis B (HB) immunization. Many studies reported that hepatitis B surface antibody (anti-HBs) seroprotection declines in children > 10 years of age. In addition many factors can influence anti-HBs titer.

Objective To measure anti-HBs titer and evaluate possible factors associated with anti-HBs titer.

Methods This cross sectional  study was conducted in children 10-15 years of age from ten schools at Tuminting District, Manado, North Sulawesi, from October to November 2014. All subjects had completed the hepatitis B immunization scheme. By stratified random sampling, 105 children were selected as subjects. Data was analyzed with SPSS version 22.

Results. From 48 schools, we selected 10 schools from which to draw a total of 105 children, but only 23 (21.9%) children had detectable anti-HBs . Of all subjects, 76 (72.4%)  were female, 78 (74.3%)  had good nutritional status, and 98 (93.3%)  had birth weight ≥2,500 grams. Data from immunization record books showed that 26 (24.8%) subjects received the HB-1 vaccination at ≤7 days of age and 45 (42.9%) subjects had a ≥2 month interval between the HB-2 and HB-3 vaccinations. Multivariate analysis showed that administration of HB-1 at ≤7 days of age  and a ≥2 month interval between HB-2 and HB-3  had significant associations with anti-HB seroprotection in children.

Conclusion A low proportion of subjects who had completed the hepatitis B immunization scheme had detectable anti-HBs titer (21.9%). Administration of HB-1 at ≤7 days of age and a ≥2-month interval between HB-2 and HB-3 vaccinations are important factors in anti-HB seroprotection in children aged 10-15 years.

References

1. Liaw YF, Chu CM. Hepatitis B virus infection. Lancet. 2009; 373:582-92.
2. Kementrrian Kesehatan RI. Pengendalian hepatitis secara komprehensif. [Cited 2014 July 27]. Available from: http://www.depkes.go.id/index.php?vw=2&id=2271.
3. Julitasari, Fahmi U. Permasalahan penyakit hepatitis virus di Indonesia. In: Zulkarnain Z, Bisanto J, Pujiarto PS, Oswari H, editors. Tinjauan komprehensif hepatitis virus pada anak. Jakarta: Bagian Ilmu Kesehatan Anak, Universitas Indonesia. 2000. p. 1-7.
4. Hou J, Liu Z, Gu F. Epidemiology and prevention of hepatitis B virus infection. Int J Med Sci. 2005;2:50-7.
5. Chen S, Chang M. Epidemiology and natural history of hepatitis B in children. In: Jonas M, editor. Viral hepatitis in children unique features and opportunities. 1st ed. New York: Humana Press; 2010. p. 13-28.
6. Hadinegoro SR. Jadwal imunisasi. In: Suyitno H, Hadinegoro S, Kartasasmita C, Ismoedijanto, Soedjatmiko, editors. Pedoman imunisasi di Indonesia. 4th edition. Jakarta: Badan Penerbit Ikatan Dokter Anak Indonesia; 2011.p.47-66.
7. Poovorawan Y, Sanpavat S, Chumdermpadetsuk S, Safary A. Long term hepatitis B vaccine in infants born to hepatitis B e antigen positive mother. Arch Dis Child Fetal Neonatal Ed. 1997;77:F47-51.
8. Ranuh I. Imunisasi upaya pencegahan primer. In: Suyitno H, Hadinegoro S, Kartasasmita C, Ismoedijanto, Soedjatmiko, editors. Pedoman imunisasi di Indonesia. 4th edition. Jakarta: Badan Penerbit Ikatan Dokter Anak Indonesia; 2011. p.2-9.
9. Aswati L, Jurnalis YD, Sayoeti Y, Bachtiar H. Faktor-faktor yang berhubungan dengan kadar anti-HBs pada anak sekolah dasar setelah 10-12 tahun imunisasi hepatitis B di kota Padang. Sari Pediatri. 2013;14:303-8.
10. Salama II, Sami SM, Salama SI, Foud WA, Abdel Hamid AT, Said ZN. Persistence of protection to hepatitis B vaccine and response to booster dose among children and adolescents in Dakahleya - Egypt. Egypt J Immunol. 2014;21:13-26.
11. Eldesoky A, Mosaad Y, Zakria Y, Hamdy S. Protective immunity after hepatitis B vaccination. Arab J of Gastroenterol. 2009;10:68-71.
12. Petersen K, Bulkow L, McMahon B, Zanis C, Gerry M, Peters H, et al. Duration of hepatitis B immunity in low risk children receiving hepatitis B vaccinations from birth. J Pediatr Infect Dis. 2004;23:650-6.
13. Jafarzadeh A, Montazerifar SJ. Persistence of anti-HBs antibody and immunological memory in children vaccinated with hepatitis B vaccine at birth. J Ayub Med Coll Abbottabad. 2006;18:4-9.
14. Lin YC, Chang MW, Ni YH, Hsu HY, Chen DS. Long term immunogenicity and efficacy of universal hepatitis B virus vaccination in Taiwan. J Infec Dis. 2003;187:134-8.
15. Suraiyah, Oswari H, Poesponegoro HD. Proporsi seroproteksi hepatitis B pada usia 10-12 tahun dengan riwayat imunisasi dasar hepatitis B lengkap pada dua sekolah dasar di Jakarta. Sari Pediatri. 2008;9:423-8.
16. Departemen Kesehatan RI. Cakupan imunisasi hepatitis B pada bayi di Indonesia. [Cited 2014 July 28]. Available from: http://bankdata.depkes.go.id/Profil/Indo04.
17. Ochirbat T, Ali M, Pagbajab N, Erkhembaatar LO, Budbazar E, Sainkhuu N, et al. Assessment of hepatitis B vaccine induced seroprotection among children 5-10 years old in Ulaanbaatar, Mongolia. Biosci Trends. 2008;2:68-74.
18. Shaaban FA, Hassanin AI, Samy SM, Salama SI, Said ZN. Long term immunity to hepatitis B among a sample of fully vaccinated children in Cairo, Egypt. East Mediterr Health J. 2007;13:750-7.
19. Ismalita. Pemberian imunisasi hepatitis B pada bayi prematur. Sari pediatri. 2003;4:163-6.
20. Karimi M, Raee A, Baghianimoghadam B, Fallahzadeh MH. Vaccine induced anti-HBs level in 5-6 year old malnourished children. Hepat Mon. 2013;13:e7048.
21. Middleman AB, Baker CJ, Kozinetz CA, Kamili S, Nguyen C, Hu DJ, et al. Duration of protection after infant hepatitis B vaccination series. Pediatrics. 2014;133:e1500-7.
22. Fadlyana E, Rusmil K, Bachtiar NS. Kekebalan dan keamanan setelah mendapat imunisasi hepatitis B rekombinan pada anak remaja. Sari Pediatri 2013;15:87-92.
23. Saari TN. American Academy of Pediatrics Committee on Infectious Diseases: immunization of preterm and low birth weight infants. Pediatrics. 2003;112:193-8.
24. Banatvala J, Van Damme P. Hepatitis B vaccine: do we need boosters?. J Viral Hepat. 2003;10:1-6.
25. Rathore MH. Hepatitis B vaccination provides protection for at least 15 years. AAP Grand Rounds. 2005;14:7-8.
26. Dahifar H. Immunogenicity of Cuban hepatitis B vaccine in Iranian children. Arch Iranian Med. 2004;7:89-92.
27. John TJ, Cooksley G, Steering Committee for the Prevention and Control of Infectious Diseases in Asia. Hepatitis B vaccine booster: is there a clinical need in high endemicity population?. J Gastroenterol Hepatol. 2005;20:5-10.
28. Rusmil K, Fadlyana E, Bachtiar NS. Booster vaksinasi hepatitis B terhadap anak yang non-responder. Sari Pediatri. 2010;12:88-91.
29. Singh AE, Plitt SS, Osiowy C, Surynicz K, Kouadjo E, Preikasitis J, et al. Factors associated with vaccine failure and vertical transmission of hepatitis B among a cohort of Canadian mothers and infants. J Viral Hepat. 2011;18:468-73.
30. Whittle H, Jaffar S, Wansbrough M, Mendy M, Dumpis U, Collincon A, et al. Observational study of vaccine efficacy 14 years after trial of hepatitis B vaccination in Gambian children. BMJ. 2002;325:569.
31. Chen CC, Yen CH, Wu WY, Hu SW, Chen SC, Bell WR, et al. Epidemiology of hepatitis B virus infection among young adults in Taiwan, China after public vaccination program. Chin Med J. 2007; 120: 1155-8.
32. Shamsizadeh A, Makvandi M, Shoshtari G. Prevalence of anti hepatitis B surface antibody among children in Ahvaz, Iran, five years after vaccination. Jundishapur J Microbiol. 2011;4:49-54.
33. Bouman A, Heineman M, Faas M. Sex hormones and the immune response in human. Hum Reprod Update. 2005;11:411-23.
34. Prayogo A, Adelia A, Cathrine, Dewina A, Pratiwi B, Ngatio B, et al. Kelengkapan imunisasi dasar pada anak usia 1-5 tahun. Sari Pediatri. 2009;11:15-20.
35. Muhammad E, Carmelia R, Yuliati, Lubis I, Manoeroeng S. Characteristic of immune response of hepatitis B immunization on infant with two different schedules. Paediatr Indones. 2001;41:197-201.
36. Van Damme P, Moiseeva A, Marichev ID, Kervyn AD, Booy R, Kuriyakose S, et al. Five years follow-up following two or three doses of a hepatitis B vaccine in adolescents aged 11-15 years: a randomised controlled study. BMC Infect Dis. 2010;10:357.
37. Hidayat B, Pujiarto P, Gunadi H. Hepatitis B. In: Suyitno H, Hadinegoro S, Kartasasmita C, Ismoedijanto, Soedjatmiko, editors. Pedoman imunisasi di Indonesia. 4th edition. Jakarta: Badan Penerbit Ikatan Dokter Anak Indonesia; 2011. p.256-63.
38. Hadinegoro S. The value of vaccination. In: Suyitno H, Hadinegoro S, Kartasasmita C, Ismoedijanto, Soedjatmiko, editors. Pedoman imunisasi di Indonesia. 4th edition. Jakarta: Badan Penerbit Ikatan Dokter Anak Indonesia; 2011. p.10-23.
39. Matondang CS, Siregar SP, Akib A. Aspek imunologi imunisasi. In: Suyitno H, Hadinegoro S, Kartasasmita C, Ismoedijanto, Soedjatmiko, editors. Pedoman imunisasi di Indonesia. 4th edition. Jakarta: Badan Penerbit Ikatan Dokter Anak Indonesia; 2011. p.24-37.
40. Handayani S, Widianingrum D, Lestari W, Sumarno, Parwati D. Uji serologi setelah imunisasi hepatitis B 3 dosis di Puskesmas Daerah Bogor dan Padang. Bul Penel Kesehatan. 2005;33:110-20.
41. Metodi J, Aboud S, Mpembeni R, Munubhi E. Immunity to hepatitis B vaccine in Tazanian under -5 children. Annals of Tropic Paediatr. 2010;30:129-36.
42. El-Gamal Y, Aly R, Hossny E, Afify E, el-Taliawy D. Response of Egyptian infants with protein calorie malnutrition to hepatitis B vaccination. J Trop Pediatr. 1996;42:144-5.
Published
2017-04-28
How to Cite
1.
Rampengan N, Hadinegoro S, Karyanti MR. Hepatitis B seroprotection in children aged 10-15 years after completion of basic hepatitis B immunizations. PI [Internet]. 28Apr.2017 [cited 18Apr.2024];57(2):76-3. Available from: https://paediatricaindonesiana.org/index.php/paediatrica-indonesiana/article/view/995
Issue
Vol 57 No 2 (2017): March 2017
Section
Articles

Authors who publish with this journal agree to the following terms:

Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Received 2016-10-31
Accepted 2017-04-11
Published 2017-04-28